Literature DB >> 10507764

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.

N Veldhoen1, J Watterson, M Brash, J Milner.   

Abstract

Mutations of the tumour suppressor p53 gene are found in a number of spontaneous canine cancers and may contribute to increased cytogenetic alterations and tumour formation. Using reverse transcription and DNA amplification, we isolated p53 cDNA from normal and tumour tissue of ten canine mammary cancer patients. DNA sequencing identified p53 mutations in three of the ten patients. These included tumour-associated p53 gene mutations within exons 2 and 5 and a germ line deletion of exons 3 to 7. These results support a role for p53 inactivation in canine mammary tumour formation and breed predisposition to cancer. Such information could prove invaluable in the successful outbreeding of inherited predisposition to cancer in the dog. A putative polymorphism was also identified at codon 69 in exon 4 and we discuss the possibility that similar polymorphisms may be associated with human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507764      PMCID: PMC2362910          DOI: 10.1038/sj.bjc.6690709

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  p53 polymorphism and risk of cervical cancer.

Authors:  A Helland; A Langerød; H Johnsen; A O Olsen; E Skovlund; A L Børresen-Dale
Journal:  Nature       Date:  1998-12-10       Impact factor: 49.962

2.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  Functions of the p53 protein in growth regulation and tumor suppression.

Authors:  J Lin; X Wu; J Chen; A Chang; A J Levine
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

Review 4.  Germline p53 mutations and heritable cancer.

Authors:  D Malkin
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

5.  A novel p53 germline alteration identified in a late onset breast cancer kindred.

Authors:  X F Sun; O Johannsson; S Håkansson; G Sellberg; B Nordenskjöld; H Olsson; A Borg
Journal:  Oncogene       Date:  1996-07-18       Impact factor: 9.867

6.  Frequency of canine and feline tumors in a defined population.

Authors:  D W MacVean; A W Monlux; P S Anderson; S L Silberg; J F Roszel
Journal:  Vet Pathol       Date:  1978-11       Impact factor: 2.221

7.  TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.

Authors:  E M Berns; J G Klijn; M Smid; I L van Staveren; M P Look; W L van Putten; J A Foekens
Journal:  Genes Chromosomes Cancer       Date:  1996-07       Impact factor: 5.006

8.  A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down.

Authors:  Y Hirano; K Yamato; N Tsuchida
Journal:  Oncogene       Date:  1995-05-18       Impact factor: 9.867

9.  Specific DNA binding by different classes of human p53 mutants.

Authors:  N Rolley; S Butcher; J Milner
Journal:  Oncogene       Date:  1995-08-17       Impact factor: 9.867

10.  A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes.

Authors:  K Yamato; M Yamamoto; Y Hirano; N Tsuchida
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

View more
  6 in total

Review 1.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 2.  A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans.

Authors:  Katie Goebel; Nancy D Merner
Journal:  Vet Med Sci       Date:  2017-03-21

Review 3.  Canine mammary tumors as a model for human disease.

Authors:  Somaia M Abdelmegeed; Sulma Mohammed
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

Review 4.  DNA damage response proteins in canine cancer as potential research targets in comparative oncology.

Authors:  Beatriz Hernández-Suárez; David A Gillespie; Aleksandra Pawlak
Journal:  Vet Comp Oncol       Date:  2022-01-10       Impact factor: 2.385

5.  The ESR1 gene is associated with risk for canine mammary tumours.

Authors:  Kaja Sverdrup Borge; Malin Melin; Patricio Rivera; Stein Istre Thoresen; Matthew Thomas Webster; Henrik von Euler; Kerstin Lindblad-Toh; Frode Lingaas
Journal:  BMC Vet Res       Date:  2013-04-10       Impact factor: 2.741

6.  Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.

Authors:  Kiyoung Eun; Min Gi Park; Yeon Woo Jeong; Yeon Ik Jeong; Sang-Hwan Hyun; Woo Suk Hwang; Sung-Hak Kim; Hyunggee Kim
Journal:  BMC Biotechnol       Date:  2019-01-03       Impact factor: 2.563

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.